Photo detail

Alan Auerbach

Stories this photo appears in:

Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict

A securities class-action filed against Puma Biotechnology Inc. resulted in a split verdict by a federal jury announced this week that allowed investors to recover $4.50 per share in damages.

Tease photo

Alan H. Auerbach

LA 500

Alan Auerbach has been chairman, chief executive and president of Puma Biotechnology since the company was founded in 2011.

Tease photo